ALKERMES | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 5.72B 1.98B 2025-06
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
ALKERMES USD 92.98M 79.19M 2025-06
Amgen USD 2.66B 1.37B 2025-06
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
J&J USD 6.94B 6.69B 2025-06
Malin Corporation EUR -1100000 400K 2024-12
Merck USD 6.36B 494M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Otsuka Holdings JPY 107.01B 17.41B 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06


ALKERMES Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.